Avalo Therapeutics AVTX Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avalo Therapeutics's income tax?
- Avalo Therapeutics (AVTX) reported income tax of $12K in Q1 2026.
- How has Avalo Therapeutics's income tax changed year-over-year?
- Avalo Therapeutics's income tax increased by 50.0% year-over-year, from $8K to $12K.
- What is the long-term trend for Avalo Therapeutics's income tax?
- Over 3 years (2021 to 2025), Avalo Therapeutics's income tax has grown at a -5.6% compound annual growth rate (CAGR), from -$196K to $165K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.